The Effect of Telenursing Interventions in Empowering Patients With COPD
NCT ID: NCT06217718
Last Updated: 2025-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2024-06-25
2024-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Self-Management Program Based on the Individual and Family Self-management Theory on Cancer Patients
NCT04822220
Tele-nursing Practices Based on Technological Competence Theory in Breast Cancer Patients
NCT05998655
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment
NCT03731585
Telerehabilitation in Survival Breast Cancer Patients
NCT05720858
The Effects of Mindfulness-based Breathing Therapy
NCT05187754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telenursing Interventions Group
Participants in this group will receive five hours of face-to-face empowerment training. After the training, the experimental group will be monitored remotely by the researcher nurse via tele-nursing interventions for 12 weeks. Participants will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. Participants will be asked to measure their oxygen saturation and pulse once a day for 12 weeks and record it on the chart. Participants will also be asked to record their complaints in their symptom diary. Participants will be called by the researcher every two weeks (on Thursdays) and informative and reminding text messages prepared specifically for the disease will be sent to the participants three times a week for 12 weeks. Participants will be able to reach the researchers by phone whenever they need.
Telenursing Interventions
Patient follow-up with phone calls and text messages
No Intervention Group
Participants in this group will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. No intervention will be taken.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telenursing Interventions
Patient follow-up with phone calls and text messages
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being literate,
* Having the cognitive and mental competence to answer questions,
* Being able to use a mobile phone,
* Disease symptoms are at a level that does not interfere with communication,
* Being in COPD Stage 2 and Stage 3 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD: Global Initiative for Chronic Obstructive Lung Disease) criteria (30% ≤ FEV1 \<80% (of expected)),
Exclusion Criteria
* Dyspnea is at a level that prevents cooperation,
* Having sensory loss regarding vision, hearing and speech,
* Refusal to sign informed consent forms
* It is the refusal of the research to complete the data collection tools.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Scientific and Technological Research Council of Turkey
OTHER
Zahide Aksoy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zahide Aksoy
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zahide Aksoy, MSc
Role: PRINCIPAL_INVESTIGATOR
Marmara University
Saime Erol, Ph.D
Role: STUDY_DIRECTOR
Marmara University
Özlem Oruç, M.D
Role: STUDY_DIRECTOR
Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, Maltepe, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MarmaraU-HEM-ZA-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.